W35--Lung Transplantation & Pulmonary Vascular Biology

Chair(s)

• 

  Keven Robinson, MD (she/her/hers)

  University of Pittsburgh
• 

  Don Hayes, Jr., MD (he/him/his)

  Div. of Pulmonary Medicine
  Cincinnati Children's Hospital Medical Center

Community Chair(s)

• 

  Dylan Mortimer, Bachlor in Fine Arts, Masters in Fine Arts (he/him/his)

  Dylan Mortimer Art

This workshop will provide a discussion on the current guidelines for referral to lung transplantation for people with CF. We will examine the characteristics of individuals with CF who undergo lung transplantation in the post-CFTR modulator era and learn about ongoing research to enhance the care of people with CF who have had lung transplants.

Presentations:

• 10:15 AM – 12:15 PM ET

  W35.1- Lung Transplant Referral Guidelines for Individuals with Cystic Fibrosis
  

  Speaker: Kathleen J. Ramos, MD MS (she/her/hers) – University of Washington
• 10:15 AM – 12:15 PM ET

  W35.2- The changing transplant landscape in the era of elexacaftor/tezacaftor/ivacaftor: a word of caution
  

  Speaker: Cecilia Chaparro, MD (she/her/hers) – Toronto General Hospital/ St. Michael's Hospital, Toronto
• 10:15 AM – 12:15 PM ET

  W35.3- Gene Expression Alterations in Lung Allografts with Acute Cellular Rejection
  

  Speaker: Andrew S. Potter, MS (he/him/his) – Cincinnati Children's Hospital Medical Center
• 10:15 AM – 12:15 PM ET

  W35.4- Role of pharmacogenomics in lung transplant with CF and Elexacaftor/Tezacaftor/Ivacaftor therapy
  

  Speaker: Aderajew Taddesse, MD, MSc, GCSRT – Brigham and Women’s Hospital (BWH) /Harvard Medical School
• 10:15 AM – 12:15 PM ET

  W35.5- Individualized Lung Transplant Care with Biomarkers for CLAD
  

  Speaker: Assem Ziady, PhD – Cincinnati Childrens Hospital